Relapse and Late Mortality in 5-Year Survivors of Myeloablative Allogeneic Hematopoietic Cell Transplantation for Chronic Myeloid Leukemia in First Chronic Phase

PURPOSE: Allogeneic hematopoietic cell transplantation (HCT) is curative therapy for chronic myeloid leukemia (CML), but its long-term outcomes are not well described. We studied the long-term outcomes of CML patients in first chronic phase who receive an allogeneic HCT. PATIENTS AND METHODS: Our st...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Goldman, John M., Majhail, Navneet S., Klein, John P., Wang, Zhiwei, Sobocinski, Kathleen A., Arora, Mukta, Horowitz, Mary M., Rizzo, J. Douglas
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2010
Matèries:
Original Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2860369/
https://ncbi.nlm.nih.gov/pubmed/20212247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.26.7757
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars